Eterna Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -69 | 0 | -55 | -69 |
EBITDA | -2,024 | -1,186 | -2,446 | -2,661 |
EBIT | -2,093 | -1,203 | -2,501 | -2,730 |
Net Income | -1,502 | -1,240 | -3,139 | -8,202 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,163 | -1,294 | -2,532 | -2,065 |
Cash | 1,884 | 3,047 | 4,315 | 1,918 |
Basic Shares | 7,854 | 8,226 | 5,179 | 3,557 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $582 | $68 | $0 |
Gross Profit | -263 | 486 | -168 | -497 |
EBITDA | -9,056 | -36,119 | -19,934 | -24,007 |
EBIT | -9,319 | -37,757 | -21,057 | -24,504 |
Net Income | -14,100 | -44,539 | -21,668 | -24,579 |
Net Change In Cash | 0 | 582 | 68 | 0 |
Free Cash Flow | -7,054 | -16,205 | -20,427 | -21,273 |
Cash | 1,884 | 1,729 | 7,575 | 11,446 |
Basic Shares | 6,307 | 909 | 354 | 203 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.15 |
2025-06-30 | -$0.61 |
2025-03-31 | -$2.31 |
2024-12-31 | -$0.15 |
